Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study - Harrington, KJ; Kong, A; Mach, N (Clinical cancer research : an official journal of the American Association for Cancer Research, 2020)
et al.